News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,902 Results
Type
Article (11050)
Company Profile (52)
Press Release (221791)
Multimedia
Podcasts (84)
Webinars (18)
Section
Business (77602)
Career Advice (1241)
Deals (12973)
Drug Delivery (68)
Drug Development (13404)
Employer Resources (141)
FDA (3993)
Job Trends (6144)
News (111177)
Policy (9257)
Tag
2027 Pharm Country Standard (3)
Academia (723)
Accelerated approval (7)
Adcomms (5)
Allergies (21)
Alliances (19795)
ALS (43)
Alzheimer's disease (385)
Antibody-drug conjugate (ADC) (94)
Approvals (4041)
Artificial intelligence (304)
Autoimmune disease (42)
Automation (25)
Bankruptcy (72)
Best Places to Work (4727)
BIOSECURE Act (19)
Biosimilars (61)
Biotechnology (43)
Bladder cancer (38)
Brain cancer (7)
Breast cancer (161)
Cancer (1208)
Cardiovascular disease (87)
Career advice (1065)
Career pathing (30)
CAR-T (82)
CDC (22)
Cell therapy (255)
Cervical cancer (18)
Clinical research (11636)
Collaboration (682)
Company closure (1)
Compensation (154)
Complete response letters (17)
COVID-19 (635)
CRISPR (30)
C-suite (517)
Cystic fibrosis (53)
Data (1415)
Decentralized trials (1)
Denatured (35)
Depression (33)
Diabetes (121)
Diagnostics (2377)
Digital health (20)
Diversity (7)
Diversity, equity & inclusion (31)
Drug discovery (109)
Drug pricing (126)
Drug shortages (14)
Duchenne muscular dystrophy (37)
Earnings (21911)
Editorial (42)
Employer branding (17)
Employer resources (118)
Events (31198)
Executive appointments (661)
FDA (4875)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (11)
Funding (535)
Gene editing (61)
Generative AI (37)
Gene therapy (196)
GLP-1 (313)
Government (1563)
Guidances (183)
Healthcare (6087)
HIV (14)
Huntington's disease (12)
IgA nephropathy (11)
Immunology and inflammation (51)
Immuno-oncology (15)
Indications (31)
Infectious disease (710)
Inflammatory bowel disease (52)
Inflation Reduction Act (11)
Influenza (31)
Intellectual property (66)
Interviews (197)
IPO (4738)
IRA (44)
Job creations (1509)
Job search strategy (899)
JPM (38)
Kidney cancer (8)
Labor market (71)
Layoffs (150)
Leadership (27)
Legal (2048)
Liver cancer (22)
Longevity (2)
Lung cancer (191)
Lymphoma (89)
Machine learning (28)
Management (43)
Manufacturing (447)
MASH (56)
Medical device (4803)
Medtech (4824)
Mergers & acquisitions (8756)
Metabolic disorders (346)
Multiple sclerosis (36)
NASH (1)
Neurodegenerative disease (85)
Neuropsychiatric disorders (22)
Neuroscience (712)
NextGen: Class of 2026 (2741)
Non-profit (1216)
Now hiring (23)
Obesity (163)
Opinion (227)
Ovarian cancer (43)
Pain (47)
Pancreatic cancer (47)
Parkinson's disease (73)
Partnered (22)
Patents (149)
Patient recruitment (95)
Peanut (6)
People (33000)
Pharmaceutical (12)
Pharmacy benefit managers (21)
Phase 1 (3341)
Phase 2 (4987)
Phase 3 (4423)
Pipeline (1611)
Policy (203)
Postmarket research (422)
Preclinical (1576)
Press Release (54)
Prostate cancer (57)
Psychedelics (18)
Radiopharmaceuticals (132)
Rare diseases (248)
Real estate (2944)
Recruiting (61)
Regulatory (6848)
Reports (33)
Research institute (814)
Resumes & cover letters (199)
Rett syndrome (3)
RNA editing (4)
RSV (20)
Schizophrenia (43)
Series A (99)
Series B (65)
Service/supplier (4)
Sickle cell disease (19)
Special edition (15)
Spinal muscular atrophy (37)
Sponsored (23)
Startups (1537)
State (1)
Stomach cancer (4)
Supply chain (57)
Tariffs (79)
The Weekly (48)
Vaccines (200)
Venture capital (53)
Weight loss (103)
Women's health (28)
Worklife (16)
Date
Last 7 days (181)
Last 30 days (665)
Last 365 days (9259)
2026 (874)
2025 (9502)
2024 (11136)
2023 (13056)
2022 (19887)
2021 (20172)
2020 (19139)
2019 (18733)
2018 (13946)
2017 (11199)
2016 (10557)
2015 (11889)
2014 (8579)
2013 (7551)
2012 (8758)
2011 (8973)
2010 (7419)
Location
Africa (367)
Alabama (22)
Alaska (4)
Arizona (114)
Arkansas (5)
Asia (16015)
Australia (2188)
California (3129)
Canada (1056)
China (435)
Colorado (135)
Connecticut (156)
Delaware (77)
Europe (31784)
Florida (524)
Georgia (96)
Hawaii (2)
Idaho (25)
Illinois (352)
India (27)
Indiana (179)
Iowa (16)
Japan (130)
Kansas (40)
Kentucky (16)
Louisiana (16)
Maine (15)
Maryland (363)
Massachusetts (2165)
Michigan (162)
Minnesota (197)
Mississippi (4)
Missouri (37)
Montana (6)
Nebraska (17)
Nevada (38)
New Hampshire (46)
New Jersey (953)
New Mexico (10)
New York (1167)
North Carolina (520)
North Dakota (7)
Northern California (1547)
Ohio (134)
Oklahoma (12)
Oregon (10)
Pennsylvania (553)
Puerto Rico (9)
Rhode Island (20)
South America (531)
South Carolina (27)
Southern California (1156)
Tennessee (44)
Texas (448)
United States (11814)
Utah (97)
Vermont (1)
Virginia (58)
Washington D.C. (25)
Washington State (168)
West Virginia (4)
Wisconsin (67)
232,902 Results for "evonik industries".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kelyniam Global Secures Exclusive U.S. License for Evonik’s VESTAKEEP® Fusion Biomaterial in Cranial Implants
November 14, 2025
·
2 min read
Press Releases
Evonik and Ethris Enter Strategic Partnership to Expand Offerings for Nucleic Acid Delivery
September 10, 2025
·
6 min read
Layoffs
Evonik to Lay Off Additional Employees, Cutting up to 260 in Germany
Evonik’s latest layoffs are tied to discontinuing production of keto acids in Hanau, Germany, by the end of next year. Earlier this year, news broke the company is also cutting up to 2,000 employees globally by 2026.
October 14, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
December 18, 2024
·
3 min read
Pharm Country
Modern Meadow and Evonik Join Forces to Revolutionize Clean Beauty with Animal-Free Collagen
Modern Meadow announced a groundbreaking partnership with Evonik, a leader in specialty ingredients for the beauty and personal care industry, to create sustainable, clean beauty products that are high-quality and animal-free.
May 2, 2023
·
3 min read
Drug Pricing
Opinion: Pricing Transparency Is Coming to the Pharma Industry
Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should embrace it.
February 2, 2026
·
5 min read
·
Joshua R. Mansbach
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, are working together to commercialize innovative 3D-printed scaffolds for bone regeneration.
March 6, 2023
·
4 min read
Pharm Country
Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
Evonik Industries AG, a leading global supplier of specialty chemicals, announced Monday their venture capital company’s strategic investment with Laxxon Medical Corporation.
March 8, 2022
·
3 min read
Press Releases
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
February 2, 2026
·
2 min read
Drug pricing
How the American Pharma Industry Became the ‘Bad Guys’
Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry hold the same respect as steelworkers or other all-American pursuits?
August 20, 2025
·
6 min read
·
Annalee Armstrong
1 of 23,291
Next
